SCHEMBL2564341

SCHEMBL2564341

Cc1ccccc1C(C#N)=C1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
MAPT P10636 4/20 0.42
CYP2C19 P33261 4/20 0.42
CYP1A2 P05177 3/20 0.42
CYP3A4 P08684 3/20 0.42
CYP2C9 P11712 3/20 0.42
RECQL P46063 1/20 0.42
NPSR1 Q6W5P4 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TSHR P16473 2/20 0.40
HCRTR1 O43613 1/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2333379 0.98 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MAPTCYP2C19
SCHEMBL29411166 0.98 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MAPTCYP2C19
SCHEMBL2565267 0.78 NPC1 (0.40) NPC1RAB9ASMN1; SMN2MAPTCYP2C19
SCHEMBL2565047 0.77 SMN1; SMN2 (0.39) NPC1RAB9ASMN1; SMN2MAPTCYP2C19
SCHEMBL2565240 0.77 NPC1 (0.42) NPC1RAB9ASMN1; SMN2MAPTCYP2C19
SCHEMBL2564868 0.77 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL2564865 0.77 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL2568762 0.77 NPC1 (0.41) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL4639985 0.73 NPC1 (0.40) NPC1RAB9ASMN1; SMN2MAPTCYP2C19
SCHEMBL3210075 0.73 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MAPTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101198585-B Cycloakylidene- (ortho substituted phenyl) -acetonitriles and their use as odorants GIVAUDAN S.A. (CH) 2011-12-07 CN claimed
EP-1890999-B1 CYCLOAKYLIDENE- (ORTHO SUBSTITUTED PHENYL) -ACETONITRILES AND THEIR USE AS ODORANTS GIVAUDAN SA (CH) 2011-11-02 EP claimed
US-7655701-B2 Cycloalkylidene-(ortho substituted phenyl)-acetonitriles and their use as odorants GIVAUDAN SA (CH) 2010-02-02 US claimed
US-20080200554-A1 Cycloaklyldiene-(Ortho Substituted Phenyl)-Acetonitriles and Their Use as Odorants GIVAUDAN SA (CH) 2008-08-21 US claimed
CN-101198585-A Cycloakylidene- (ortho substituted phenyl) -acetonitriles and their use as odorants GIVAUDAN SA (CH) 2008-06-11 CN claimed
EP-1890999-A1 CYCLOAKYLIDENE- (ORTHO SUBSTITUTED PHENYL) -ACETONITRILES AND THEIR USE AS ODORANTS Givaudan SA (CH) 2008-02-27 EP claimed
WO-2006133592-A1 CYCLOAKYLIDENE- (ORTHO SUBSTITUTED PHENYL) -ACETONITRILES AND THEIR USE AS ODORANTS GIVAUDAN SA (CH) 2006-12-21 WO claimed
CN-109415306-A The preparation method of 2- cyclohexylidene -2- phenylacetonitrile and its odorous analogue 阿甘香气及精细化学有限公司 2019-03-01 CN disclosed
CN-101198585-B Cycloakylidene- (ortho substituted phenyl) -acetonitriles and their use as odorants GIVAUDAN S.A. (CH) 2011-12-07 CN disclosed
EP-1890999-B1 CYCLOAKYLIDENE- (ORTHO SUBSTITUTED PHENYL) -ACETONITRILES AND THEIR USE AS ODORANTS GIVAUDAN SA (CH) 2011-11-02 EP disclosed
US-7655701-B2 Cycloalkylidene-(ortho substituted phenyl)-acetonitriles and their use as odorants GIVAUDAN SA (CH) 2010-02-02 US disclosed
US-20080200554-A1 Cycloaklyldiene-(Ortho Substituted Phenyl)-Acetonitriles and Their Use as Odorants GIVAUDAN SA (CH) 2008-08-21 US disclosed
CN-101198585-A Cycloakylidene- (ortho substituted phenyl) -acetonitriles and their use as odorants GIVAUDAN SA (CH) 2008-06-11 CN disclosed
EP-1890999-A1 CYCLOAKYLIDENE- (ORTHO SUBSTITUTED PHENYL) -ACETONITRILES AND THEIR USE AS ODORANTS Givaudan SA (CH) 2008-02-27 EP disclosed
WO-2006133592-A1 CYCLOAKYLIDENE- (ORTHO SUBSTITUTED PHENYL) -ACETONITRILES AND THEIR USE AS ODORANTS GIVAUDAN SA (CH) 2006-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200554-A1 Cycloaklyldiene-(Ortho Substituted Phenyl)-Acetonitriles and Their Use as Odorants OR10J3, OR51E2, OPRD1 NPC1 2179/4885RAB9A 4166/4885SMN1; SMN2 3788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.